Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-22-004081
Filing Date
2022-04-15
Accepted
2022-04-15 11:30:04
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27677
2 filename2.txt TEXT-EXTRACT 1512
  Complete submission text file 0000000000-22-004081.txt   40367
Mailing Address 1201 N. MARKET STREET SUITE 111 WILMINGTON DE 19801
Business Address 1201 N. MARKET STREET SUITE 111 WILMINGTON DE 19801 484-254-6134
NRX Pharmaceuticals, Inc. (Filed for) CIK: 0001719406 (see all company filings)

EIN.: 822844431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations